Retatrutide Also known as: LY3437943, Triple Hormone Receptor Agonist, GIP/GLP-1/Glucagon Receptor Agonist, GLP-3R, LY3437943, LY-3437943, GLP-3RT CAS: 2381089-83-2 Available Suppliers & Pricing Summary Retatrutide (LY3437943) is a novel synthetic peptide that acts as a triple agonist at the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors
Beef, lamb, fish, eggs, and dairy products all supply substantial amounts
Mild prick only
image credit- freepik Novo Nordisk has announced that the US Food and Drug Administration (FDA) has approved once-daily Wegovy pill, the first oral GLP-1 medicine for obesity in the US
8(4):pkae054 Han JS, Kim GH, Kim J, Jeon US, Joo KW, Na KY et al (2002) Secretory-defect distal renal tubular acidosis is associated with transporter defect in H(+)-ATPase and anion exchanger-1